000			01530 a2200409 4500
005			20250513230538.0
264		0	_c20010308
008			200103s 0 0 eng d
022			_a0090-8258
024	7		_a10.1006/gyno.2000.6051 _2doi
040			_aNLM _beng _cNLM
100	1		_aBell, M C
245	0	0	_aTopotecan concomitant with primary brachytherapy radiation in patients with cervical carcinoma: a phase I trial. _h[electronic resource]
260			_bGynecologic oncology _cFeb 2001
300			_a128-31 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAdult
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aBrachytherapy _xadverse effects
650	0	4	_aCarcinoma, Squamous Cell _xdrug therapy
650	0	4	_aCombined Modality Therapy
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDose-Response Relationship, Radiation
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLeukopenia _xchemically induced
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Staging
650	0	4	_aTopotecan _xadministration & dosage
650	0	4	_aUterine Cervical Neoplasms _xdrug therapy
700	1		_aDavidson, S A
700	1		_aMathis, J M
700	1		_aAmpil, F
773	0		_tGynecologic oncology _gvol. 80 _gno. 2 _gp. 128-31
856	4	0	_uhttps://doi.org/10.1006/gyno.2000.6051 _zAvailable from publisher's website
999			_c11101303 _d11101303